moderna vaccine

• Are 4th COVID-19 doses needed amid Omicron spread? Experts weigh in

  For the general healthy population, there's no rush get a second COVID-19 booster, experts say, given the protection from a third dose and low transmission rate of the virus.

  Health

  Jun 23
  
• Updated Moderna COVID-19 booster can combat Omicron subvariants, vaccine maker says

  Moderna's updated COVID-19 vaccine generated a strong immune response against the fast-spreading Omicron subvariants BA.4 and BA.5.

  Health

  Jun 22
  
• Advertisement
• Moderna asks U.S. to approve COVID-19 vaccine for kids under 6

  Moderna submitted data to the U.S. Food and Drug Administration that it hopes will prove two low-dose shots can protect babies, toddlers and preschoolers from COVID-19.

  World

  Apr 28
• Advertisement
• Moderna aims for fall release of COVID-19 Omicron vaccine

  Before Omicron came along, Moderna was studying a combination shot that added protection against an earlier COVID-19 variant named Beta.

  Health

  Apr 19
• London Middlesex residents line up for 4th dose of COVID-19 vaccine

  Londoners were lined up outside the Western Fair Agriplex Thursday to get their fourth dose of a COVID-19 vaccine, but not everyone was satisfied with the experience.

  Health

  Apr 7
• U.S. FDA authorizes 2nd COVID-19 booster for older Americans

  The Food and Drug Administration's decision opens a fourth dose of the Pfizer or Moderna vaccines to people age 50 and older at least four months after their previous booster.

  Health

  Mar 29
• Moderna’s low-dose COVID-19 vaccine works on kids under 6, company says

  Moderna’s COVID-19 vaccine works in babies, toddlers and preschoolers the company announced Wednesday — and if regulators agree, they could begin kids under 6 by summer.

  Health

  Mar 23
• Moderna asks U.S. to approve 2nd COVID-19 booster dose for all adults

  The request is broader than rival pharmaceutical company Pfizer's request earlier this week for the regulator to approve a second booster shot for all seniors.

  Health

  Mar 17
• Advertisement
• Moderna to set up Africa’s first mRNA vaccine manufacturing facility

  Moderna said it expects to invest about $500 million in the Kenyan facility and supply as many as 500 million doses of mRNA vaccines to the continent each year.

  World

  Mar 7
• Advertisement
• Johnson & Johnson temporarily halts COVID-19 vaccine production: report

  Johnson & Johnson have temporarily shut down the only plant making usable batches of its COVID-19 vaccine, a New York Times report says.

  Health

  Feb 8